Relative Bioavailability of a Single Oral Dose of BI 425809 When Administered Alone or in Combination With Multiple Oral Doses of Itraconazole in Healthy Male Subjects

• Status: Completed
• Trial end date: 2015-03-01

Summary

To investigate whether and to what extent co-administration of multiple doses of itraconazole affect single dose pharmacokinetics of BI 425809 in healthy male subjects

• Phase: Phase 1

Details

• Lead Sponsor: Boehringer Ingelheim
• Treatments: BI 425809; Hydroxyitraconazole; Itraconazole